4//SEC Filing
Ollier Michele 4
Accession 0000904454-11-000319
CIK 0001338042other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 2:25 PM ET
Size
6.0 KB
Accession
0000904454-11-000319
Insider Transaction Report
Form 4
Ollier Michele
Director10% Owner
Transactions
- Sale
Common Stock
2011-06-29$14.61/sh−877,723$12,822,392→ 2,168,435 total(indirect: See footnote)
Footnotes (3)
- [F1]These securities are owned directly by Index Ventures III (Jersey), L.P. ("IVIII Jersey"), Index Ventures III (Delaware), L.P. ("IVIII Delaware") and Index Ventures Parallel Entrepreneur Fund (Jersey), L.P. ("IVPEF"), of which Index Venture Associates III Ltd. is the general partner, and by Yucca Partners L.P. (Jersey Branch) as Administrator of the Index Co-Investment Scheme ("Yucca"). The Reporting Person, who is a Director of the Issuer, is a partner of Index Ventures, which is affiliated with the foregoing funds, however the Reporting Person disclaims beneficial ownership of all such shares held by the foregoing funds, except to the extent of her proportionate pecuniary interest therein.
- [F2]Such shares of Common Stock were sold in a registered secondary offering by the Issuer as follows: 314,515 shares by IVIII Jersey; 546,906 shares by IVIII Delaware; 10,281 shares by IVPEF; and 6,021 shares by Yucca.
- [F3]IVIII Jersey is the direct beneficial owner of 569,571 shares of Common Stock; IVIII Delaware is the direct beneficial owner of 1,564,809 shares of Common Stock; IVPEF is the direct beneficial owner of 21,704 shares of Common Stock; and Yucca is the direct beneficial owner of 12,531 shares of Common Stock.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeother
Related Parties
1- filerCIK 0001503685
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 2:25 PM ET
- Size
- 6.0 KB